Clinical trial
Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma…
NCT00838513 · Alexion Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00838513 |
|---|---|
| Title | Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS) |
| Official title | An Open-label, Multi-center Controlled Clinical Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (AHUS) |
| Acronym | aHUS |
| Lead sponsor | Alexion Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atypical Hemolytic Uremic Syndrome |
| Intervention type | Drug |
| Interventions | eculizumab |
| Enrollment | 15 |
| Start date | Jul 1, 2009 |
| Primary completion | Oct 1, 2010 |
| Completion | Dec 1, 2013 |
| First posted | Feb 6, 2009 |
| Last update posted | Jul 23, 2015 |
| Countries | Canada, France, Germany, Italy, Netherlands, Sweden, United Kingdom |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: